Skip to main content
OpenTrials

Clinical trial condition

Advanced Non Small Cell Lung Cancer

Explore clinical trials studying Advanced Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Advanced Non Small Cell Lung Cancer trial results

Recruiting

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

NCT06908993

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Besançon - CHU Besançon, France
  • Bordeaux - Institut Bergonie Bordeaux, France
  • Brest - CHU Brest, France
  • Caen - CRLCC Caen, France
View all 29 locations
View Trial Details
Completed

AZD9291 First Time In Patients Ascending Dose Study

NCT01802632

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +13 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

NCT02157883

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +9 more
Locations
  • Research Site San Diego, California, United States
  • Research Site Cleveland, Ohio, United States
  • Research Site Edegem, Belgium
  • Research Site Ghent, Belgium
View all 16 locations
View Trial Details
Completed

Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer

NCT02163733

Conditions
Advanced (Inoperable) Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, +9 more
Locations
  • Research Site Dijon, France
  • Research Site Lyon, France
  • Research Site Saint-Herblain, France
  • Research Site Seoul, South Korea
View all 13 locations
View Trial Details

Related conditions